polycystic ovary syndrome. Polycystic ovarian syndrome
Conditions
Interventions
Intervention 1: Intervention group receive acarbose 100 mg/day for 3 months. This method that in the first week they receive 1 tablet, second week two tablets and third week three tablets per day. Int
Treatment - Drugs
Intervention group receive acarbose 100 mg/day for 3 months. This method that in the first week they receive 1 tablet, second week two tablets and third week three tablets per day.
Control group receive metformin 500 mg/day for 3 months. This method that in the first week they receive 1 tablet, second week two tablets and third week three tablets per day.
Sponsors
Vice Chancellor for Research, Kurdistan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: age 20-40 years, women with polycystic ovary syndrome diagnosed by the rotterdam consensus criteria. Exclusion criteria: Smoking, Cushing's syndrome, thyroid function disorders, androgen secreting tumors, patients with liver disease, kidney disease, heart disease, diabetes, and use of other drugs for polycystic ovary syndrome.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hirsutism. Timepoint: Before intervention -Three months after intervention. Method of measurement: Using Feriedman and Galway Scale.;Fasting insulin serum level. Timepoint: Before intervention -Three months after intervention. Method of measurement: Elisa assays.;Fasting sugar serum level. Timepoint: Before intervention -Three months after intervention. Method of measurement: Enzyme.;Blood pressure. Timepoint: Before intervention -Three months after intervention. Method of measurement: Barometers. | — |
Secondary
| Measure | Time frame |
|---|---|
| Triglyceride serum level. Timepoint: Before intervention -Three months after intervention. Method of measurement: Serological test with Electro Komolynsans method.;Cholestrol serum level. Timepoint: Before intervention -Three months after intervention. Method of measurement: Serological test with Electro Komolynsans method.;LDL serum level. Timepoint: Before intervention -Three months after intervention. Method of measurement: Serological test with Electro Komolynsans method.;HDL serum level. Timepoint: Before intervention -Three months after intervention. Method of measurement: Serological test with Electro Komolynsans method. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSomaye Mohammadpour
Kurdistan University of Medical Sciences
Outcome results
None listed